The role of DNA hypomethylation in the control of stromelysin gene expression

Biochemical and Biophysical Research Communications

Volumn 342, Issue 4, 2006, Pages 1233-1239

  Couillard, Julie ^a   Demers, Mélanie ^a   Lavoie, Geneviève ^a   St Pierre, Yves ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

5 Aza 2 deoxycytidine; Cancer biology; Colon carcinoma; DNA methylation; Gene transcription; Lymphoma; Matrix metalloproteinase; Transcription; Zebularine

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; DNA METHYLTRANSFERASE INHIBITOR; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 2; ZEBULARINE;

ARTICLE; CELL STRAIN HCT116; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; NEOPLASM; PRIORITY JOURNAL; TUMOR CELL LINE; WILD TYPE;

CELL LINE; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOBLASTOMA; HUMANS; KIDNEY; MATRIX METALLOPROTEINASE 3;

EID: 33644884949     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.068     Document Type: Article

References (29)

1. C.E. Brinckerhoff, and L.M. Matrisian Matrix metalloproteinases: a tail of a frog that became a prince Nat. Rev. Mol. Cell Biol. 3 2002 207 214
2. X.S. Puente, L.M. Sanchez, C.M. Overall, and C. Lopez-Otin Human and mouse proteases: a comparative genomic approach Nat. Rev. Genet. 4 2003 544 558
3. K.L. Sirum, and C.E. Brinckerhoff Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts Biochemistry 28 1989 8691 8698
4. C.E. Brinckerhoff, K.L. Sirum-Connolly, M.J. Karmilowicz, and D.T. Auble Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts Matrix Suppl. 1 1992 165 175
5. L.J. Windsor, H. Grenett, B. Birkedal-Hansen, M.K. Bodden, J.A. Engler, and H. Birkedal-Hansen Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters J. Biol. Chem. 268 1993 17341 17347
6. C. Van Themsche, T. Alain, A.E. Kossakowska, S. Urbanski, E.F. Potworowski, and Y. St-Pierre Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo J. Immunol. 173 2004 3605 3611
7. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
8. S.E. Goelz, B. Vogelstein, S.R. Hamilton, and A.P. Feinberg Hypomethylation of DNA from benign and malignant human colon neoplasms Science 228 1985 187 190
9. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat. Rev. Cancer 4 2004 143 153
10. J. Wahlfors, H. Hiltunen, K. Heinonen, E. Hamalainen, L. Alhonen, and J. Janne Genomic hypomethylation in human chronic lymphocytic leukemia Blood 80 1992 2074 2080
11. N. Nakamura, and K. Takenaga Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines Clin. Exp. Metastasis 16 1998 471 479
12. Y. Yamada, L. Jackson-Grusby, H. Linhart, A. Meissner, A. Eden, H. Lin, and R. Jaenisch Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis Proc. Natl. Acad. Sci. USA 102 2005 13580 13585
13. A.M. De Marzo, V.L. Marchi, E.S. Yang, R. Veeraswamy, X. Lin, and W.G. Nelson Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis Cancer Res. 59 1999 3855 3860
14. I. Rhee, K.E. Bachman, B.H. Park, K.W. Jair, R.W. Yen, K.E. Schuebel, H. Cui, A.P. Feinberg, C. Lengauer, K.W. Kinzler, S.B. Baylin, and B. Vogelstein DNMT1 and DNMT3b cooperate to silence genes in human cancer cells Nature 416 2002 552 556
15. A.R. Karpf, and S. Matsui Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells Cancer Res. 65 2005 8635 8639
16. M.F. Paz, S. Wei, J.C. Cigudosa, S. Rodriguez-Perales, M.A. Peinado, T.H. Huang, and M. Esteller Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases Hum. Mol. Genet. 12 2003 2209 2219
17. N. Sato, A. Maitra, N. Fukushima, N.T. van Heek, H. Matsubayashi, C.A. Iacobuzio-Donahue, C. Rosty, and M. Goggins Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma Cancer Res. 63 2003 4158 4166
18. E. Chicoine, P.O. Esteve, O. Robledo, C. Van Themsche, E.F. Potworowski, and Y. St-Pierre Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression Biochem. Biophys. Res. Commun. 297 2002 765 772
19. P.A. Jones, and J.D. Buckley The role of DNA methylation in cancer Adv. Cancer Res. 54 1990 1 23
20. J.P. Issa, P.M. Vertino, J. Wu, S. Sazawal, P. Celano, B.D. Nelkin, S.R. Hamilton, and S.B. Baylin Increased cytosine DNA-methyltransferase activity during colon cancer progression J. Natl. Cancer Inst. 85 1993 1235 1240
21. J. Frigola, X. Sole, M.F. Paz, V. Moreno, M. Esteller, G. Capella, and M.A. Peinado Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer Hum. Mol. Genet. 14 2005 319 326
22. M.D. Sternlicht, M.J. Bissell, and Z. Werb The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter Oncogene 19 2000 1102 1113
23. Y. Oshimo, H. Nakayama, R. Ito, Y. Kitadai, K. Yoshida, K. Chayama, and W. Yasui Promoter methylation of cyclin D2 gene in gastric carcinoma Int. J. Oncol. 23 2003 1663 1670
24. V. Badal, L.S. Chuang, E.H. Tan, S. Badal, L.L. Villa, C.M. Wheeler, B.F. Li, and H.U. Bernard CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression J. Virol. 77 2003 6227 6234
25. A. de Capoa, A. Musolino, S. Della Rosa, P. Caiafa, L. Mariani, F. Del Nonno, A. Vocaturo, R.P. Donnorso, A. Niveleau, and C. Grappelli DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples Oncol. Rep. 10 2003 545 549
26. M. Nakayama, M. Wada, T. Harada, J. Nagayama, H. Kusaba, K. Ohshima, M. Kozuru, H. Komatsu, R. Ueda, and M. Kuwano Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias Blood 92 1998 4296 4307
27. A.M. Mansour, J. Drevs, N. Esser, F.M. Hamada, O.A. Badary, C. Unger, I. Fichtner, and F. Kratz A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2 Cancer Res. 63 2003 4062 4066
28. E. Van Valckenborgh, D. Mincher, A. Di Salvo, I. Van Riet, L. Young, B. Van Camp, and K. Vanderkerken Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model Leukemia 19 2005 1628 1633
29. W.E. Samlowski, S.A. Leachman, M. Wade, P. Cassidy, P. Porter-Gill, L. Busby, R. Wheeler, K. Boucher, F. Fitzpatrick, D.A. Jones, and A.R. Karpf Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation J. Clin. Oncol. 23 2005 3897 3905